GREY WOLF THERAPEUTICS LIMITED - ABINGDON
| Company Profile | Company Filings |
Overview
GREY WOLF THERAPEUTICS LIMITED is a Private Limited Company from ABINGDON ENGLAND and has the status: Active.
GREY WOLF THERAPEUTICS LIMITED was incorporated 6 years ago on 29/09/2017 and has the registered number: 10989365. The accounts status is SMALL and accounts are next due on 30/09/2024.
GREY WOLF THERAPEUTICS LIMITED was incorporated 6 years ago on 29/09/2017 and has the registered number: 10989365. The accounts status is SMALL and accounts are next due on 30/09/2024.
GREY WOLF THERAPEUTICS LIMITED - ABINGDON
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
99 PARK DRIVE
ABINGDON
OX14 4RY
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 27/10/2023 | 10/11/2024 |
Map
ENGLAND
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| MR RAPHAEL WISNIEWSKI | Apr 1970 | French | Director | 2018-03-29 | CURRENT |
| MS MARIE-CLAIRE PEAKMAN | Jul 1969 | American | Director | 2022-12-23 | CURRENT |
| MS RABAB NASRALLAH | Aug 1986 | Australian | Director | 2022-12-23 | CURRENT |
| PETER JOYCE | Apr 1982 | British | Director | 2017-09-29 | CURRENT |
| THOMAS DAVID MCCARTHY | Jun 1967 | Australian | Director | 2017-09-29 | CURRENT |
| MISS EMMA JOHNSON | Jun 1996 | British | Director | 2022-12-23 | CURRENT |
| DR THIERRY HERCEND | Mar 1952 | French | Director | 2018-03-29 | CURRENT |
| DR SALLY MARIANNE DEWHURST | Mar 1990 | British | Director | 2022-12-23 | CURRENT |
| MR BRENTON KARL AHRENS | Mar 1963 | American | Director | 2018-03-29 | CURRENT |
| MS SAMANTHA ANN HARRIS | Secretary | 2022-06-22 | CURRENT | ||
| DR STUART THOMAS ONIONS | Jul 1979 | British | Director | 2018-03-18 UNTIL 2018-03-29 | RESIGNED |
Persons with Significant Control
| Name | Active from | Born | Address | Level of control |
|---|---|---|---|---|
| Biodiscovery 5 Fpci | 2019-02-12 - 2019-02-12 | Paris 75001 |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
|
| Canaan Xi L.P. | 2019-02-12 - 2019-02-12 | Menlo Park California |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
|
| Mr Peter Joyce | 2017-09-29 - 2018-03-29 | 4/1982 | Oxford |
Ownership of shares 50 to 75 percent Voting rights 50 to 75 percent Right to appoint and remove directors |
| Thomas David Mccarthy | 2017-09-29 - 2018-03-29 | 6/1967 | Oxford |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| ACCOUNTS - Final Accounts | 2023-07-01 | 31-12-2022 | 9,568,847 Cash 10,130,895 equity |
| ACCOUNTS - Final Accounts preparation | 2021-04-21 | 31-12-2020 | 862,006 Cash 9,325,031 equity |